Cellular regulation of endothelial nitric oxide synthase

American Journal of Physiology - Renal Physiology

Volumn 280, Issue 2 49-2, 2001, Pages

  Govers, Roland ^a   Rabelink, Ton J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Cardiovascular physiology; Cell biology; Renal physiology

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ACYLATION; BIOAVAILABILITY; CALCIUM MOBILIZATION; CARDIOVASCULAR FUNCTION; CELL METABOLISM; CELLULAR DISTRIBUTION; ENDOTHELIUM CELL; ENZYME REGULATION; ENZYME SYNTHESIS; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; SHEAR STRESS; TRANSCRIPTION REGULATION;

EID: 0035018871     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.2001.280.2.f193     Document Type: Review

References (176)

1. Abu-Soud HM and Stuehr DJ. Nitric oxide synthases reveal a role for calmodulin in controlling electron transfer. Proc Natl Acad Sci USA 90: 10769-10772, 1993.
2. Ahn KY, Mohaupt MG, Madsen KM, and Kone BC. In situ hybridization localization of mRNA encoding inducible nitric oxide synthase in rat kidney. Am J Physiol Renal Fluid Electrolyte Physiol 267: F748-F757, 1994.
3. Alonso J, Sanchez de Miguel L, Monton M, Casado S, and Lopez-Farre A. Endothelial cytosolic proteins bind to the 3′ untranslated region of endothelial nitric oxide synthase mRNA: regulation by tumor necrosis factor alpha. Mol Cell Biol 17: 5719-5726, 1997.
4. Anderson RG. Caveolae: where incoming and outgoing messengers meet. Proc Natl Acad Sci USA 90: 10909-10913, 1993.
5. Andries LJ, Brutsaert DL, and Sys SU. Nonuniformity of endothelial constitutive nitric oxide synthase distribution in cardiac endothelium. Circ Res 82: 195-203, 1998.
6. Arnal JF, Yamin J, Dockery S, and Harrison DG. Regulation of endothelial nitric oxide synthase mRNA, protein, and activity during cell growth. Am J Physiol Cell Physiol 267: C1381-C1388, 1994.
7. Awolesi MA, Sessa WC, and Sumpio BE. Cyclic strain upregulates nitric oxide synthase in cultured bovine aortic endothelial cells. J Clin Invest 96: 1449-1454, 1995.
8. Ayajiki K, Kindermann M, Hecker M, Fleming I, and Busse R. Intracellular pH and tyrosine phosphorylation but not calcium determine shear stress-induced nitric oxide production in native endothelial cells. Circ Res 78: 750-758, 1996.
9. Barton M, Luscher TF, and Rabelink TJ. Say NO to hypertension. Science 281: 1961, 1998.
10. Bilderback TR, Gazula VR, Lisanti MP, and Dobrowsky RT. Caveolin interacts with Trk A and p75(NTR) and regulates neurotrophin signaling pathways. J Biol Chem 274: 257-263, 1999.
11. Blair A, Shaul PW, Yuhanna IS, Conrad PA, and Smart EJ. Oxidized low density lipoprotein displaces endothelial nitric-oxide synthase (eNOS) from plasmalemmal caveolae and impairs eNOS activation. J Biol Chem 274: 32512-32519, 1999.
12. Bloch KD. Regulation of endothelial NO synthase mRNA stability: RNA-binding proteins crowd on the 3′-untranslated region. Circ Res 85: 653-665, 1999.
13. Bouloumie A, Schinikerth VB, and Busse R. Vascular endothelial growth factor up-regulates nitric oxide synthase expression in endothelial cells. Cardiovasc Res 41: 773-780, 1999.
14. Braam B. Renal endothelial and macula densa NOS: integrated response to changes in extracellular fluid volume. Am J Physiol Regulatory Integrative Comp Physiol 276: R1551-R1561, 1999.
15. Brezis M, Heyman SN, Dinour D, Epstein FH, and Rosen S. Role of nitric oxide in renal medullary oxygenation. Studies in isolated and intact rat kidneys. J Clin Invest 88: 390-395, 1991.
16. Brock TA and Capasso EA. Thrombin and histamine activate phospholipase C in human endothelial cells via a phorbol estersensitive pathway. J Cell Physiol 136: 54-62, 1988.
17. Bruning TA, Chang PC, Blauw GJ, Vermeij P, and van Zwieten PA. Serotonin-induced vasodilatation in the human forearm is mediated by the "nitric oxide-pathway": no evidence for involvement of the 5-HT3-receptor. J Cardiovasc Pharmacol 22: 44-51, 1993.
18. Buckley BJ, Mirza Z, and Whorton AR. Regulation of Ca(2+)-dependent nitric oxide synthase in bovine aortic endothelial cells. Am J Physiol Cell Physiol 269: C757-C765, 1995.
19. Buga GM, Griscavage JM, Rogers NE, and Ignarro LJ. Negative feedback regulation of endothelial cell function by nitric oxide. Circ Res 73: 808-812, 1993.
20. Casino PR, Kilcoyne CM, Quyyumi AA, Hoeg JM, and Panza JA. The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients. Circulation 88: 2541-2547, 1993.
21. Chen KD, Li YS, Kim M, Li S, Yuan S, Chien S, and Shyy JY. Mechanotransduction in response to shear stress. Roles of receptor tyrosine kinases, integrins, and Shc. J Biol Chem 274: 18393-18400, 1999.
22. Chen Z, Yuhanna IS, Galchevagargova Z, Karas RH, Mendelsohn RE, and Shaul PW. Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 103: 401-406, 1999.
23. Chen ZP, Mitchelhill KI, Michell BJ, Stapleton D, Rodriguez-Crespo I, Witters LA, Power DA, Ortiz de Montellano PR, and Kemp BE. AMP-activated protein kinase phosphorylation of endothelial NO synthase. FEBS Lett 443: 285-289, 1999.
24. 2+-dependent NOS in renal cortex of ANG II-infused hypertensive rats. Am J Physiol Renal Physiol 277: F797-F804, 1999.
25. Cieslik K, Lee CM, Tang JL, and Wu KK. Transcriptional regulation of endothelial nitric-oxide synthase by an interaction between casein kinase 2 and protein phosphatase 2A. J Biol Chem 274: 34669-34675, 1999.
26. Conrad PA, Smart EJ, Ying YS, Anderson RG, and Bloom GS. Caveolin cycles between plasma membrane caveolae and the Golgi complex by microtubule-dependent and microtubuleindependent steps. J Cell Biol 131: 1421-1433, 1995.
27. Cooke JP, Rossitch E Jr, Andon NA, Loscalzo J, and Dzau VJ. Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator. J Clin Invest 88: 1663-1671, 1991.
28. Corson MA, James NL, Latta SE, Nerem RM, Berk BC, and Harrison DG. Phosphorylation of endothelial nitric oxide synthase in response to fluid shear stress. Circ Res 79: 984-991, 1996.
29. Couet J, Li S, Okamoto T, Ikezu T, and Lisanti MP. Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. J Biol Chem 272: 6525-6533, 1997.
30. Couet J, Sargiacomo M, and Lisanti MP. Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities. J Biol Chem 272: 30429-30438, 1997.
31. Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dzau VJ, and Cooke JP. L-Arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest 90: 1248-1253, 1992.
32. Danthuluri NR, Cybulsky MI, and Brock TA. ACh-induced calcium transients in primary cultures of rabbit aortic endothelial cells. Am J Physiol Heart Circ Physiol 255: H1549-H1553, 1988.
33. Davda RK, Stepniakowski KT, Lu G, Ullian ME, Goodfriend TL, and Egan BM. Oleic acid inhibits endothelial nitric oxide synthase by a protein kinase C-independent mechanism. Hypertension 26: 764-770, 1995.
34. Deliconstantinos G, Villiotou V, and Stavrides JC. Modulation of particulate nitric oxide synthase activity and peroxynitrite synthesis in cholesterol enriched endothelial cell membranes. Biochem Pharmacol 49: 1589-1600, 1995.
35. Deng A and Baylis C. Locally produced EDRF controls preglomerular resistance and ultrafiltration coefficient. Am J Physiol Renal Fluid Electrolyte Physiol 264: F212-F215, 1993.
36. 2 bradykinin receptors and the receptor-coupled Galpha subunits Galphaq and Galphai in caveolae in DDT1 MF-2 smooth muscle cells. J Biol Chem 272: 17858-17866, 1997.
37. Dijkhorst-Oei LT, Rabelink TJ, Boer P, and Koomans HA. Nifedipine attenuates systemic and renal vasoconstriction during nitric oxide inhibition in humans. Hypertension 29: 1192-1198, 1997.
38. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, and Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 399: 601-605, 1999.
39. Drummond GR, Cai H, Davis ME, Ramasamy S, and Harrison DG. Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression by hydrogen peroxide. Circ Res 86: 347-354, 2000.
40. Engelman JA, Chu C, Lin A, Jo H, Ikezu T, Okamoto T, Kohtz DS, and Lisanti MP. Caveolin-mediated regulation of signaling along the p42/44 MAP kinase cascade in vivo. A role for the caveolin-scaffolding domain. FEBS Lett 428: 205-211, 1998.
41. Etscheid BG and Villereal ML. Coupling of bradykinin receptors to phospholipase C in cultured fibroblasts is mediated by a G-protein. J Cell Physiol 140: 264-271, 1989.
42. Feng Y, Venema VJ, Venema RC, Tsai N, Behzadian MA, and Caldwell RB. VEGF-induced permeability increase is mediated by caveolae. Invest Ophthalmol Vis Sci 40: 157-167, 1999.
43. Feron O, Dessy C, Moniotte S, Desager JP, and Balligand JL. Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase. J Clin Invest 103: 897-905, 1999.
44. Feron O, Michel JB, Sase K, and Michel T. Dynamic regulation of endothelial nitric oxide synthase: complementary roles of dual acylation and caveolin interactions. Biochemistry 37: 193-200, 1998.
45. Feron O, Saldana F, Michel JB, and Michel T. The endothelial nitric-oxide synthase-caveolin regulatory cycle. J Biol Chem 273: 3125-3128, 1998.
46. Feron O, Smith TW, Michel T, and Kelly RA. Dynamic targeting of the agonist-stimulated m2 muscarinic acetylcholine receptor to caveolae in cardiac myocytes. J Biol Chem 272: 17744-17748, 1997.
47. Fischer S, Clauss M, Wiesnet M, Renz D, Schaper W, and Karliczek GF. Hypoxia induces permeability in brain microvessel endothelial cells via VEGF and NO. Am J Physiol Cell Physiol 276: C812-C820, 1999.
48. 2+-independent activation of the endothelial nitric oxide synthase in response to tyrosine phosphatase inhibitors and fluid shear stress. Circ Res 82: 686-695, 1998.
49. 2+-independent activation of the endothelial nitric oxide synthase. Proc Natl Acad Sci USA 96: 1123-1128, 1999.
50. Fra AM, Williamson E, Simons K, and Parton RG. Detergent-insoluble glycolipid microdomains in lymphocytes in the absence of caveolae. J Biol Chem 269: 30745-30748, 1994.
51. Fujimoto T. Calcium pump of the plasma membrane is localized in caveolae. J Cell Biol 120: 1147-1157, 1993.
52. Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, and Sessa WC. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399: 597-601, 1999.
53. Gallis B, Corthals GL, Goodlett DR, Ueba H, Kim F, Presnell SR, Figeys D, Harrison DG, Berk BC, Aebersold R, and Corson MA. Identification of flow-dependent endothelial nitric-oxide synthase phosphorylation sites by mass spectrometry and regulation of phosphorylation and nitric oxide production by the phosphatidylinositol 3-kinase inhibitor LY294002. J Biol Chem 274: 30101-30108, 1999.
54. Garcia-Cardena G, Fan R, Shah V, Sorrentino R, Cirino G, Papapetropoulos A, and Sessa WC. Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature 392: 821-824, 1998.
55. Garcia-Cardena G, Fan R, Stern DF, Liu J, and Sessa WC. Endothelial nitric oxide synthase is regulated by tyrosine phosphorylation and interacts with caveolin-1. J Biol Chem 271: 27237-27240, 1996.
56. Garcia-Cardena G, Martasek P, Masters BS, Skidd PM, Couet J, Li S, Lisanti MP, and Sessa WC. Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the NOS-caveolin binding domain in vivo. J Biol Chem 272: 25437-25440, 1997.
57. Garcia-Cardena G, Oh P, Liu J, Schnitzer JE, and Sessa WC. Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling. Proc Natl Acad Sci USA 93: 6448-6453, 1996.
58. Ghosh S, Gachhui R, Crooks C, Wu C, Lisanti MP, and Stuehr DJ. Interaction between caveolin-1 and the reductase domain of endothelial nitric-oxide synthase. Consequences for catalysis. J Biol Chem 273: 22267-22271, 1998.
59. Goetz RM, Thatte HS, Prabhakar P, Cho MR, Michel T, and Golan DE. Estradiol induces the calcium-dependent translocation of endothelial nitric oxide synthase. Proc Nat Acad Sci USA 96: 2788-2793, 1999.
60. 2 receptor. Binding of an inhibitory peptide to the oxygenase domain blocks uncoupled NADPH oxidation. J Biol Chem 275: 5291-5296, 2000.
61. Gorodinsky A and Harris DA. Glycolipid-anchored proteins in neuroblastoma cells form detergent-resistant complexes without caveolin. J Cell Biol 129: 619-627, 1995.
62. 2+ homeostasis and formation of cGMP and prostacyclin. Am J Physiol Cell Physiol 265: C1620-C1629, 1993.
63. Gratton JP, Fontana J, O'Connor DS, Garcia-Cardena G, McCabe TJ, and Sessa WC. Reconstitution of an endothelial nitric oxide synthase, hsp90 and caveolin-1 complex in vitro: evidence that hsp90 facilitates calmodulin stimulated displacement of eNOS from caveolin-1. J Biol Chem 275: 22268-22272, 2000.
64. Gustavsson J, Parpal S, Karlsson M, Ramsing C, Thorn H, Borg M, Lindroth M, Peterson KH, Magnusson KE, and Stralfors P. Localization of the insulin receptor in caveolae of adipocyte plasma membrane. FASEB J 13: 1961-1971, 1999.
65. Heeringa P, van Goor H, Moshage H, Klok PA, Huitema MG, de Jager A, Schep AJ, and Kallenberg CG. Expression of iNOS, eNOS, and peroxynitrite-modified proteins in experimental anti-myeloperoxidase associated crescentic glomerulonephritis. Kidney Int 53: 382-393, 1998.
66. Hirata K, Kuroda R, Sakoda T, Katayama M, Inoue N, Suematsu M, Kawashima S, and Yokoyama M. Inhibition of endothelial nitric oxide synthase activity by protein kinase C. Hypertension 25: 180-185, 1995.
67. Hirata K, Miki N, Kuroda Y, Sakoda T, Kawashima S, and Yokoyama M. Low concentration of oxidized low-density lipoprotein and lysophosphatidylcholine upregulate constitutive nitric oxide synthase mRNA expression in bovine aortic endothelial cells. Circ Res 76: 958-962, 1995.
68. Huk I, Nanobashvili J, Neumayer C, Punz A, Mueller M, Afkhampour K, Mittlboeck M, Losert U, Polterauer P, Roth E, Patton S, and Malinski T. L-Arginine treatment alters the kinetics of nitric oxide and superoxide release and reduces ischemia/reperfusion injury in skeletal muscle. Circulation 96: 667-675, 1997.
69. + channels mediate EDRF release to flow but not agonists in rabbit aorta. Am J Physiol Heart Circ Physiol 266: H590-H596, 1994.
70. Hutcheson IR and Griffith TM. Mechanotransduction through the endothelial cytoskeleton: mediation of flow- but not agonist-induced EDRF release. Br J Pharmacol 118: 720-726, 1996.
71. Igarashi J, Thatte HS, Prabhakar P, Golan DE, and Michel T. Calcium-independent activation of endothelial nitric oxide synthase by ceramide. Proc Natl Acad Sci USA 96: 12583-12588, 1999.
72. Inoue N, Venema RC, Sayegh HS, Ohara Y, Murphy TJ, and Harrison DG. Molecular regulation of the bovine endothelial cell nitric oxide synthase by transforming growth factor-beta 1. Arterioscler Thromb Vasc Biol 15: 1255-1261, 1995.
73. Ishii M, Shimizu S, Yamamoto T, Momose K, and Kuroiwa Y. Acceleration of oxidative stress-induced endothelial cell death by nitric oxide synthase dysfunction accompanied with decrease in tetrahydrobiopterin content. Life Sci 61: 739-747, 1997.
74. Ito S, Arima S, Ren YL, Juncos LA, and Carretero OA. Endothelium-derived relaxing factor/nitric oxide modulates angiotensin II action in the isolated microperfused rabbit afferent but not efferent arteriole. J Clin Invest 91: 2012-2019, 1993.
75. Ito S, Carretero OA, and Abe K. Nitric oxide in the juxtaglomerular apparatus. Kidney Int Suppl 55: S6-S8, 1996.
76. 2 receptor with endothelial nitric-oxide synthase. J Biol Chem 273: 24025-24029, 1998.
77. Ju H, Zou R, Venema VJ, and Venema RC. Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity. J Biol Chem 272: 18522-18525, 1997.
78. Kakoki M, Hirata Y, Hayakawa H, Suzuki E, Nagata D, Tojo A, Nishimatsu H, Nakanishi N, Hattori Y, Kikuchi K, Nagano T, and Omata M. Effects of tetrahydrobiopterin on endothelial dysfunction in rats with ischemic acute renal failure. J Am Soc Nephrol 11: 301-309, 2000.
79. Kelm M, Feelisch M, Krebber T, Motz W, and Strauer BE. Mechanisms of histamine-induced coronary vasodilatation: H1-receptor-mediated release of endothelium-derived nitric oxide. J Vasc Res 30: 132-138, 1993.
80. Kim HP, Lee JY, Jeong JK, Bae SW, Lee HK, and Jo I. Nongenomic stimulation of nitric oxide release by estrogen is mediated by estrogen receptor alpha localized in caveolae. Biochem Biophys Res Commun 263: 257-262, 1999.
81. Kone BC. Localization and regulation of nitric oxide synthase isoforms in the kidney. Semin Nephrol 19: 230-241, 1999.
82. Kone BC. Nitric oxide in renal health and disease. Am J Kidney Dis 30: 311-333, 1997.
83. Kroll J and Waltenberger J. VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR). Biochem Biophys Res Commun 252: 743-746, 1998.
84. Kuboki K, Jiang ZY, Takahara N, Ha SW, Igarashi M, Yamauchi T, Feener EP, Herbert TP, Rhodes CJ, and King GL. Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulin. Circulation 101: 676-681, 2000.
85. Kurose I, Kubes P, Wolf R, Anderson DC, Paulson J, Miyasaka M, and Granger DN. Inhibition of nitric oxide production. Mechanisms of vascular albumin leakage. Circ Res 73: 164-171, 1993.
86. Kurzchalia TV, Dupree P, Parton RG, Kellner R, Virta H, Lehnert M, and Simons K. VIP21, a 21-kD membrane protein is an integral component of trans-Golgi-network-derived transport vesicles. J Cell Biol 118: 1003-1014, 1992.
87. Landreth GE, Williams LK, and Rieser GD. Association of the epidermal growth factor receptor kinase with the detergent-insoluble cytoskeleton of A431 cells. J Cell Biol 101: 1341-1350, 1985.
88. Laufs U, La Fata V, Plutzky J, and Liao JK. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97: 1129-1135, 1998.
89. Li S, Couet J, and Lisanti MP. Src tyrosine kinases, Galpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. J Biol Chem 271: 29182-29190, 1996.
90. Li S, Okamoto T, Chun M, Sargiacomo M, Casanova JE, Hansen SH, Nishimoto I, and Lisanti MP. Evidence for a regulated interaction between heterotrimeric G proteins and caveolin. J Biol Chem 270: 15693-15701, 1995.
91. Liao JK, Shin WS, Lee WY, and Clark SL. Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J Biol Chem 270: 319-324, 1995.
92. Liu J, Garcia Cardena G, and Sessa WC. Biosynthesis and palmitoylation of endothelial nitric oxide synthase: mutagenesis of palmitoylation sites, cysteines-15 and/or -26, argues against depalmitoylation-induced translocation of the enzyme. Biochemistry 34: 12333-12340, 1995.
93. Liu J, Garcia-Cardena G, and Sessa WC. Palmitoylation of endothelial nitric oxide synthase is necessary for optimal stimulated release of nitric oxide: implications for caveolae localization. Biochemistry 35: 13277-13281, 1996.
94. Liu J, Hughes TE, and Sessa WC. The first 35 amino acids and fatty acylation sites determine the molecular targeting of endothelial nitric oxide synthase into the Golgi region of cells: a green fluorescent protein study. J Cell Biol 137: 1525-1535, 1997.
95. Liu J, Oh P, Horner T, Rogers RA, and Schnitzer JE. Organized endothelial cell surface signal transduction in caveolae distinct from glycosylphosphatidylinositol-anchored protein microdomains. J Biol Chem 272: 7211-7222, 1997.
96. Liu SM and Sundqvist T. Nitric oxide and cGMP regulate endothelial permeability and F-actin distribution in hydrogen peroxide-treated endothelial cells. Exp Cell Res 235: 238-244, 1997.
97. Lu JL, Schmiege LM, 3rd Kuo L, and Liao JC. Downregulation of endothelial constitutive nitric oxide synthase expression by lipopolysaccharide. Biochem Biophys Res Commun 225: 1-5, 1996.
98. Marrero MB, Venema VJ, Ju H, He H, Liang HY, Caldwell RB, and Venema RC. Endothelial nitric oxide synthase interactions with G-protein-coupled receptors. Biochem J 343: 335-340, 1999.
99. Marsden PA, Heng HH, Scherer SW, Stewart RJ, Hall AV, Shi XM, Tsui LC, and Schappert KT. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem 268: 17478-17488, 1993.
100. Mashiach E, Sela S, Winaver J, Shasha SM, and Kristal B. Renal ischemia-reperfusion injury: contribution of nitric oxide and renal blood flow. Nephron 80: 458-467, 1998.
101. Mattson DL, Roman RJ, and Cowley AW Jr. Role of nitric oxide in renal papillary blood flow and sodium excretion. Hypertension 19: 766-769, 1992.
102. Mattson DL and Wu F. Nitric oxide synthase activity and isoforms in rat renal vasculature. Hypertension 35: 337-341, 2000.
103. McCabe TJ, Fulton D, Roman LJ, and Sessa WC. Enhanced electron flux and reduced calmodulin dissociation may explain "calcium-independent" eNOS activation by phosphorylation. J Biol Chem 275: 6123-6128, 2000.
104. McDonald KK, Zharikov S, Block ER, and Kilberg MS. A caveolar complex between the cationic amino acid transporter 1 and endothelial nitric-oxide synthase may explain the "arginine paradox." J Biol Chem 272: 31213-31216, 1997.
105. McQuillan LP, Leung GK, Marsden PA, Kostyk SK, and Kourembanas S. Hypoxia inhibits expression of eNOS via transcriptional and posttranscriptional mechanisms. Am J Physiol Heart Circ Physiol 267: H1921-H1927, 1994.
106. 2+-calmodulin and caveolin. J Biol Chem 272: 15583-15586, 1997.
107. Michel JB, Feron O, Sase K, Prabhakar P, and Michel T. Caveolin versus calmodulin. Counterbalancing allosteric modulators of endothelial nitric oxide synthase. J Biol Chem 272: 25907-25912, 1997.
108. Michel T, Li GK, and Busconi L. Phosphorylation and subcellular translocation of endothelial nitric oxide synthase. Proc Natl Acad Sci USA 90: 6252-6256, 1993.
109. Michell BJ, Griffiths JE, Mitchelhill KI, Rodriguez-Crespo I, Tiganis T, Bozinovski S, de Montellano PR, Kemp BE, and Pearson RB. The Akt kinase signals directly to endothelial nitric oxide synthase. Curr Biol 12: 845-848, 1999.
110. Mineo C, Gill GN, and Anderson GW. Regulated migration of epidermal growth factor receptor from caveolae. J Biol Chem 274: 30636-30643, 1999.
111. Mitani Y, Maruyama K, and Sakurai M. Prolonged administration of L-arginine ameliorates chronic pulmonary hypertension and pulmonary vascular remodeling in rats. Circulation 96: 689-697, 1997.
112. Navarro-Antolin J, Rey-Campos J, and Lamas S. Transcriptional induction of endothelial nitric oxide gene by cyclosporine A. A role for activator protein-1. J Biol Chem 275: 3075-3080, 2000.
113. Ni Z, Wang XQ, and Vaziri ND. Nitric oxide metabolism in erythropoietin-induced hypertension: effect of calcium channel blockade. Hypertension 32: 724-729, 1998.
114. Nishida K, Harrison DG, Navas JP, Fisher AA, Dockery SP, Uematsu M, Nerem RM, Alexander RW, and Murphy TJ. Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase. J Clin Invest 90: 2092-2096, 1992.
115. Noris M, Morigi M, Donadelli R, Aiello S, Foppolo M, Todeschini M, Orisio S, Remuzzi G, and Remuzzi A. Nitric oxide synthesis by cultured endothelial cells is modulated by flow conditions. Circ Res 76: 536-543, 1995.
116. Ohara Y, Sayegh HS, Yamin JJ, and Harrison DG. Regulation of endothelial constitutive nitric oxide synthase by protein kinase C. Hypertension 25: 415-420, 1995.
117. Ohashi Y, Katayama M, Hirata K, Suematsu M, Kawashima S, and Yokoyama M. Activation of nitric oxide synthase from cultured aortic endothelial cells by phospholipids. Biochem Biophys Res Commun 195: 1314-1320, 1993.
118. Ohno M, Gibbons GH, Dzau VJ, and Cooke JP. Shear stress elevates endothelial cGMP. Role of a potassium channel and G protein coupling. Circulation 88: 193-197, 1993.
119. Palmer RM, Ashton DS, and Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333: 664-666, 1988.
120. Papapetropoulos A, Garciacardena G, Madri JA, and Sessa WC. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest 100: 3131-3139, 1997.
121. Parton RG. Caveolae and caveolins. Curr Opin Cell Biol 8: 542-548, 1996.
122. Parton RG and Simons K. Digging into caveolae. Science 269: 1398-1399, 1995.
123. Peterson TE, Poppa V, Ueba H, Wu A, Yan C, and Berk BC. Opposing effects of reactive oxygen species and cholesterol on endothelial nitric oxide synthase and endothelial cell caveolae. Circ Res 85: 29-37, 1999.
124. Plato CF, Shesely EG, and Garvin JL. eNOS mediates L-arginine-induced inhibition of thick ascending limb chloride flux. Hypertension 35: 319-323, 2000.
125. Pou S, Keaton L, Surichamorn W, and Rosen GM. Mechanism of superoxide generation by neuronal nitric-oxide synthase. J Biol Chem 274: 9573-9580, 1999.
126. Pou S, Pou WS, Bredt DS, Snyder SH, and Rosen GM. Generation of superoxide by purified brain nitric oxide synthase. J Biol Chem 267: 24173-24176, 1992.
127. Prabhakar P, Thatte HS, Goetz RM, Cho MR, Golan DE, and Michel T. Receptor-regulated translocation of endothelial nitric-oxide synthase. J Biol Chem 273: 27383-27388, 1998.
128. Pratt WB. The role of the hsp90-based chaperone system in signal transduction by nuclear receptors and receptors signaling via MAP kinase. Annu Rev Pharmacol Toxicol 37: 297-326, 1997.
129. Rahman MM, Varghese Z, Fuller BJ, and Moorhead JF. Renal vasoconstriction induced by oxidized LDL is inhibited by scavengers of reactive oxygen species and L-arginine. Clin Nephrol 51: 98-107, 1999.
130. Raman CS, Li HY, Martasek P, Kral V, Masters BSS, and Poulos TL. Crystal structure of constitutive endothelial nitric oxide synthase: a paradigm for pterin function involving a novel metal center. Cell 95: 939-950, 1998.
131. Rizzo V, McIntosh DP, Oh P, and Schnitzer JE. In situ flow activates endothelial nitric oxide synthase in luminal caveolae of endothelium with rapid caveolin dissociation and calmodulin association. J Biol Chem 273: 34724-34729, 1998.
132. Rizzo V, Sung A, Oh P, and Schnitzer JE. Rapid mechanotransduction in situ at the luminal cell surface of vascular endothelium and its caveolae. J Biol Chem 273: 26323-26329, 1998.
133. Robinson LJ and Michel T. Mutagenesis of palmitoylation sites in endothelial nitric oxide synthase identifies a novel motif for dual acylation and subcellular targeting. Proc Natl Acad Sci USA 92: 11776-11780, 1995.
134. Robinson LJ, Weremowicz S, Morton CC, and Michel T. Isolation and chromosomal localization of the human endothelial nitric oxide synthase (NOS3) gene. Genomics 19: 350-357, 1994.
135. Roman RJ and Zou AP. Influence of the renal medullary circulation on the control of sodium excretion. Am J Physiol Regulatory Integrative Comp Physiol 265: R963-R973, 1993.
136. Sakoda T, Hirata K, Kuroda R, Miki N, Suematsu M, Kawashima S, and Yokoyama M. Myristoylation of endothelial cell nitric oxide synthase is important for extracellular release of nitric oxide. Mol Cell Biochem 152: 143-148, 1995.
137. Salom MG, Lahera V, Miranda-Guardiola F, and Romero JC. Blockade of pressure natriuresis induced by inhibition of renal synthesis of nitric oxide in dogs. Am J Physiol Renal Fluid Electrolyte Physiol 262: F718-F722, 1992.
138. Schnitzer JE, McIntosh DP, Dvorak AM, Liu J, and Oh P. Separation of caveolae from associated microdomains of GPI-anchored proteins. Science 269: 1435-1439, 1995.
139. Schwartz D, Mendonca M, Schwartz I, Xia Y, Satriano J, Wilson CB, and Blantz RC. Inhibition of constitutive nitric oxide synthase (NOS) by nitric oxide generated by inducible NOS after lipopolysaccharide administration provokes renal dysfunction in rats. J Clin Invest 100: 439-448, 1997.
140. Sessa WC, Garcia-Cardena G, Liu J, Keh A, Pollock JS, Bradley J, Thiru S, Braverman IM, and Desai KM. The Golgi association of endothelial nitric oxide synthase is necessary for the efficient synthesis of nitric oxide. J Biol Chem 270: 17641-17644, 1995.
141. Sessa WC, Harrison JK, Barber CM, Zeng D, Durieux ME, D'Angelo DD, Lynch KR, and Peach MJ. Molecular cloning and expression of a cDNA encoding endothelial cell nitric oxide synthase. J Biol Chem 267: 15274-15276, 1992.
142. Shah V, Wiest R, Garcia-Cardena G, Cadelina G, Groszmann RJ, and Sessa WC. Hsp90 regulation of endothelial nitric oxide synthase contributes to vascular control in portal hypertension. Am J Physiol Gastrointest Liver Physiol 277: G463-G468, 1999.
143. Shaul PW, Smart EJ, Robinson LJ, German Z, Yuhanna IS, Ying Y, Anderson RG, and Michel T. Acylation targets endothelial nitric-oxide synthase to plasmalemmal caveolae. J Biol Chem 271: 6518-6522, 1996.
144. Smart EJ, Graf GA, McNiven MA, Sessa WC, Engelman JA, Scherer PE, Okamoto T, and Lisanti MP. Caveolins, liquid-ordered domains, and signal transduction. Mol Cell Biol 19: 7289-7304, 1999.
145. Sowa G, Liu J, Papapetropoulos A, Rex-Haffner M, Hughes TE, and Sessa WC. Trafficking of endothelial nitric-oxide synthase in living cells. Quantitative evidence supporting the role of palmitoylation as a kinetic trapping mechanism limiting membrane diffusion. J Biol Chem 274: 22524-22531, 1999.
146. Stanboli A and Morin AM. Nitric oxide synthase in cerebrovascular endothelial cells is inhibited by brefeldin A. Neurosci Lett 171: 209-212, 1994.
147. Stroes E, Hijmering M, Vanzandvoort M, Wever R, Rabelink TJ, and Vanfaassen EE. Origin of superoxide production by endothelial nitric oxide synthase. FEBS Lett 438: 161-164, 1998.
148. Stroes E, Kastelein J, Cosentino F, Erkelens W, Wever R, Koomans H, Luscher T, and Rabelink T. Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. J Clin Invest 99: 41-46, 1997.
149. Sung CP, Arleth AJ, Shikano K, Zabko-Potapovich B, and Berkowitz BA. Effect of trypsinization in cell culture on bradykinin receptors in vascular endothelial cells. Biochem Pharmacol 38: 696-699, 1989.
150. Tan EQ, Gurjar MV, Sharma RV, and Bhalla RC. Estrogen receptor-alpha gene transfer into bovine aortic endothelial cells induces eNOS gene expression and inhibits cell migration. Cardiovasc Res 43: 788-797, 1999.
151. Teichert AM, Miller TL, Tai SC, Wang Y, Bei X, Robb GB, Phillips MJ, and Marsden PA. In vivo expression profile of an endothelial nitric oxide synthase promoter-reporter transgene. Am J Physiol Heart Circ Physiol 278: H1352-H1361, 2000.
152. Toyoshima H, Nasa Y, Hashizume Y, Koseki Y, Isayama Y, Kohsaka Y, Yamada T, and Takeo S. Modulation of cAMP-mediated vasorelaxation by endothelial nitric oxide and basal cGMP in vascular smooth muscle. J Cardiovasc Pharmacol 32: 543-551, 1998.
153. Traylor LA and Mayeux PR. Superoxide generation by renal proximal tubule nitric oxide synthase. Nitric Oxide 1: 432-438, 1997.
154. Vasquez-Vivar J, Hogg N, Martasek P, Karoui H, Pritchard KA Jr, and Kalyanaraman B. Tetrahydrobiopterindependent inhibition of superoxide generation from neuronal nitric oxide synthase. J Biol Chem 274: 26736-26742, 1999.
155. Vasquez-Vivar J, Kalyanaraman B, Martasek P, Hogg N, Masters BSS, Karoui H, Tordo P, and Pritchard KA. Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci USA 95: 9220-9225, 1998.
156. Vaziri ND, Ding Y, and Ni Z. Nitric oxide synthase expression in the course of lead-induced hypertension. Hypertension 34: 558-62, 1999.
157. Vaziri ND and Wang XQ. cGMP-mediated negative-feedback regulation of endothelial nitric oxide synthase expression by nitric oxide. Hypertension 34: 1237-1241, 1999.
158. Venema RC, Sayegh HS, Arnal JF, and Harrison DG. Role of the enzyme calmodulin-binding domain in membrane association and phospholipid inhibition of endothelial nitric oxide synthase. J Biol Chem 270: 14705-14711, 1995.
159. Venema VJ, Marrero MB, and Venema RC. Bradykinin-stimulated protein tyrosine phosphorylation promotes endothelial nitric oxide synthase translocation to the cytoskeleton. Biochem Biophys Res Commun 226: 703-710, 1996.
160. Venema VJ, Zou R, Ju H, Marrero MB, and Venema RC. Caveolin-1 detergent solubility and association with endothelial nitric oxide synthase is modulated by tyrosine phosphorylation. Biochem Biophys Res Commun 236: 155-161, 1997.
161. Verhagen AM, Rabelink TJ, Braam B, Opgenorth TJ, Grone HJ, Koomans HA, and Joles JA. Endothelin A receptor blockade alleviates hypertension and renal lesions associated with chronic nitric oxide synthase inhibition. J Am Soc Nephrol 9: 755-762, 1998.
162. Vos I, Joles JA, Schurink M, Weckbecker M, Stajanovic T, Rabelink TJ, and Grone HJ. Inhibition of inducible nitric oxide synthase improves graft function and reduces tubulointerstitial injury in renal allograft rejection. Eur J Pharmacol 391: 31-38, 2000.
163. Wang XQ and Vaziri ND. Erythropoietin depresses nitric oxide synthase expression by human endothelial cells. Hypertension 33: 894-899, 1999.
164. Waugh MG, Lawson D, and Hsuan JJ. Epidermal growth factor receptor activation is localized within low-buoyant density, non-caveolar membrane domains. Biochem J 337: 591-597, 1999.
165. Wever RMF, van Dam T, van Rijn HJ, de Groot F, and Rabelink TJ. Tetrahydrobiopterin regulates superoxide and nitric oxide generation by recombinant endothelial nitric oxide synthase. Biochem Biophys Res Commun 237: 340-344, 1997.
166. Woda BA and McFadden ML. Ligand-induced association of rat lymphocyte membrane proteins with the detergent-insoluble lymphocyte cytoskeletal matrix. J Immunol 131: 1917-1919, 1983.
167. Xia Y, Roman LJ, Masters BS, and Zweier JL. Inducible nitric-oxide synthase generates superoxide from the reductase domain. J Biol Chem 273: 22635-22639, 1998.
168. Yamamoto M, Toya Y, Jensen RA, and Ishikawa Y. Caveolin is an inhibitor of platelet-derived growth factor receptor signaling. Exp Cell Res 247: 380-388, 1999.
169. Yan SR, Fumagalli L, and Berton G. Activation of SRC family kinases in human neutrophils. Evidence that p58C-FGR and p53/56LYN redistributed to a Triton X-100-insoluble cytoskeletal fraction, also enriched in the caveolar protein caveolin, display an enhanced kinase activity. FEBS Lett 380: 198-203, 1996.
170. Yeh DC, Duncan JA, Yamashita S, and Michel T. Depalmitoylation of endothelial nitric-oxide synthase by acyl-protein thioesterase 1 is potentiated by Ca(2+)-calmodulin. J Biol Chem 274: 33148-33154, 1999.
171. G-hydroxy-L-arginine by cultured endothelial cells. Proc Natl Acad Sci USA 88: 11172-11176, 1991.
172. Zembowicz A, Tang JL, and Wu KK. Transcriptional induction of endothelial nitric oxide synthase type III by lysophosphatidylcholine. J Biol Chem 270: 17006-17010, 1995.
173. Zeng G, Nystrom FH, Ravichandran LV, Cong LN, Kirby M, Mostowski H, and Quon MJ. Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation 101: 1539-1545, 2000.
174. Zeng G and Quon MJ. Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. J Clin Invest 98: 894-898, 1996.
175. Zheng J, Bird IM, Melsaether AN, and Magness RR. Activation of the mitogen-activated protein kinase cascade is necessary but not sufficient for basic fibroblast growth factor- and epidermal growth factor-stimulated expression of endothelial nitric oxide synthase in ovine fetoplacental artery endothelial cells. Endocrinology 140: 1399-1407, 1999.
176. Ziegler T, Silacci P, Harrison VJ, and Hayoz D. Nitric oxide synthase expression in endothelial cells exposed to mechanical forces. Hypertension 32: 351-355, 1998.